Key Facts
Raised £32.4 million in private funding, working with 10 + partners across UK, US, Canada and Europe; Mia has been developed with over 3 million images; world leading results: enables breast screening with 50% less human reader resources required; picks up over 50% of cancers missed by readers
Successes in UK/NHS
Kheiron is working in partnership with the East Midlands Radiology Consortium (EMRAD) to test and validate Mia. EMRAD is an established collaboration of seven NHS Acute Trusts in the East Midlands and the largest collaborative network of hospitals in the UK to share a singular image sharing platform. We have been granted government funding for this project as part of NHS England’s Test Bed Program. The Test Bed is progressing well and we are hoping to deploy Mia into a selection of EMRAD sites by the end of June 2020. We are proud to say that this project was referenced within the recent NHSX report ‘Artificial Intelligence: How to get it right’.Company details
Solutions
Augmenting healthcare professionals
Providing advanced screening and diagnostics
Specialism
Decision Support and treatment planning
Specialised diagnostics
Company details
Want to connect with this innovator?
Make an enquiryWebsite
www.kheironmed.com/Details
View on Companies HouseMarkets already exporting to
EMEA, Australia/New Zealand, USA - Kheiron has presence with partners in the United States, the UK, and Hungary. Mia currently has a CE mark and we are in the process of finalising the framework for a full commercial launch in development with our current NHS partners.
Desired Markets
UK, EMEA, Australia/New Zealand, USA
Desired customer types
Hospitals and healthcare organisations. Decision makers are Radiology Dept Chiefs (clinical leads), Radiology Administrators, System Procurement, IT Infrastructure Leaders, CMIOs, Cybersecurity leads, Health Ministry Leaders (EMEA/APAC)